Romero-Gómez Benjamín, Guerrero-Alonso Paula, Carmona-Torres Juan Manuel, Pozuelo-Carrascosa Diana P, Laredo-Aguilera José Alberto, Cobo-Cuenca Ana Isabel
Hospital El Tomillar de Sevilla, Servicio Andaluz de Salud (SAS), 41500 Alcalá de Guadaira, Spain.
Centro de Salud Najera, Servicio Rioja Salud, 26300 Najera, Spain.
J Clin Med. 2020 Nov 27;9(12):3864. doi: 10.3390/jcm9123864.
The use of levothyroxine is not always related to the elimination of the symptoms of hypothyroidism. The aim of this study is to compare the health-related quality of life (HRQOL) of a group of hypothyroid women under levothyroxine treatment with that of a group of non-hypothyroid women.
A case-control study was performed. We used convenience sampling. The case group consisted of 152 levothyroxine-treated hypothyroid women; the control group consisted of 238 women without hypothyroidism disorders. All of the participants were euthyroid according to the clinical practice guidelines. We used as instruments the Short Form-12 questionnaire (SF-12v1) and a sociodemographic questionnaire.
Hypothyroid women scored significantly lower in HRQOL in SF-12v1 mental and physical components than the control group (mental component summary: 41.23 ± 12.12 vs. 46.45 ± 10.22, 0.001; physical component summary: 49.64 ± 10.16 vs. 54.75 ± 5.76, 0.001). body mass index (BMI) and age showed an influence on the physical component ( 0.001 in both variables). Adjusted for age and BMI, hypothyroidism was still related to worse scores ( 0.001).
Despite being euthyroid, women with hypothyroidism showed a poorer quality of life than women without hypothyroidism. Health professionals need to assess the HRQOL of women with hypothyroidism. Further research on HRQOL and hypothyroidism is needed.
左甲状腺素的使用并不总是与甲状腺功能减退症状的消除相关。本研究的目的是比较一组接受左甲状腺素治疗的甲状腺功能减退女性与一组非甲状腺功能减退女性的健康相关生活质量(HRQOL)。
进行了一项病例对照研究。我们采用方便抽样。病例组由152名接受左甲状腺素治疗的甲状腺功能减退女性组成;对照组由238名无甲状腺功能减退症的女性组成。根据临床实践指南,所有参与者的甲状腺功能均正常。我们使用简短健康调查问卷(SF - 12v1)和一份社会人口学调查问卷作为工具。
甲状腺功能减退女性在SF - 12v1心理和身体成分的HRQOL得分显著低于对照组(心理成分总分:41.23±12.12对46.45±10.22,P = 0.001;身体成分总分:49.64±10.16对54.75±5.76,P = 0.001)。体重指数(BMI)和年龄对身体成分有影响(两个变量的P值均为0.001)。在调整年龄和BMI后,甲状腺功能减退仍与较差的得分相关(P = 0.001)。
尽管甲状腺功能正常,但甲状腺功能减退女性的生活质量比无甲状腺功能减退的女性更差。卫生专业人员需要评估甲状腺功能减退女性的HRQOL。需要对HRQOL和甲状腺功能减退进行进一步研究。